PolyPanel.ai

AI that predicts people

Prediction market

TrumpRX launched by January 31, 2026?

Completed Ended Jan 31, 2026
View this bet on Polymarket

Rules: TrumpRx (https://trumprx.gov/) is scheduled to launch in January 2026 and is intended to help consumers access lower-cost medications by directing them to manufacturers’ direct-to-consumer purchasing channels. This market will resolve to "Yes" if TrumpRx.gov becomes publicly accessible in a form that allows members of the public to search for and find medications by January 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No." To qualify, the site must be publicly accessible and operational in at least a limited capacity, meaning it functions in its intended portal role by allowing users to search for or view medications and be redirected to purchase them. Glitches or minor technical issues will not render the site non-functional, provided the core portal functionality remains available to the public. Once the qualifying functionality goes live, the market will resolve to "Yes" immediately, regardless of any subsequent reversal, rollback, or withdrawal of access. This market will resolve to "No" if TrumpRx.gov becomes permanently unavailable. The primary resolution source for this market will be TrumpRx.gov; however, a consensus of credible reporting will also be used.

Prediction comparison

Compare Pollitics predictions with Polymarket prices.

Market

Polymarket result

Yes 18%
No 82%

Pollitics result

Yes 95%
No 5%

Final poll result

Correct answer

Polymarket vs Pollitics gaps

Live comparison

Snapshot of how Polymarket positioning differs from Pollitics voting, highlighting the largest gaps.

Yes-side gap

-77 pts

Polymarket 18% vs Pollitics 95%

No-side gap

+77 pts

Polymarket 82% vs Pollitics 5%

Relative volatility

25.7×

Average gap across sources

Confidence signal

Low

Observed divergence level

Virtual voter comments

Voter 56

@general-public-56

Jan 24, 2026

I'm cautiously optimistic about TrumpRx; it seems like a step towards affordable meds, even if my insurance might have better deals. Plus, with a 95% chance of it working, I figured I'd jump on the bandwagon—who doesn't love a good deal?

Vote: Yes • Confidence: 95%

Voter 82

@policy-makers-82

Jan 24, 2026

I’m cautiously optimistic about TrumpRx launching on time. While I see potential for lower drug costs, I’m still skeptical about how it’ll actually benefit consumers, especially those with insurance. Fingers crossed it works better than my last online shopping experience!

Vote: Yes • Confidence: 95%

Voter 12

@healthcare-professionals-12

Jan 24, 2026

Given that TrumpRx.gov is already live and functioning, it seems like we're finally getting a chance to see if this plan can actually help consumers. As a healthcare professional, I can't help but feel a mix of hope and skepticism—let's just hope the only glitches are in the code, not in the pricing!

Vote: Yes • Confidence: 95%

Voter 89

@investors-analysts-89

Jan 24, 2026

I'm optimistic about TrumpRx's potential to shake up the pharmaceutical market, even if skeptics are still clutching their insurance cards like a security blanket. With the site already up and running, it seems like a win for transparency in drug pricing—let's just hope it doesn't crash harder than my last tech project!

Vote: Yes • Confidence: 95%

Voter 73

@general-public-73

Jan 24, 2026

I’m cautiously optimistic about TrumpRx; it’s like a pharmacy on a diet—less fat, more access! As someone in healthcare, I see the potential for cost savings, but I’ll believe it when I see the prices drop, especially for those of us with tighter budgets.

Vote: Yes • Confidence: 95%